BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5533302)

  • 1. Clinical experience with glibenclamide in 129 unselected diabetic patients.
    Davidson M; Lewis AA; de Mowbray RR
    Postgrad Med J; 1970 Dec; ():Suppl:70-7. PubMed ID: 5533302
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with glibenclamide.
    Galbraith HJ
    Postgrad Med J; 1970 Dec; ():Suppl:95-7. PubMed ID: 5533306
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
    Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
    Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of glibenclamide and chlorpropamide in the treatment of non-obese maturity onset diabetics.
    Johnston AT; Ireland JT
    Postgrad Med J; 1970 Dec; ():Suppl:98-100. PubMed ID: 5500517
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 11. Glibenclamide for secondary failure of other sulphonylureas.
    Stowers JM
    Postgrad Med J; 1970 Dec; ():Suppl;63-5. PubMed ID: 5500519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K; Steen B; Svanborg A
    Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of adult diabetes with a diet and with oral hypoglycemic agents].
    Douady H
    Soins; 1979 Mar; 24(5):7-12. PubMed ID: 254371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of diabetes treatment with delayed-action Silubin. 2].
    Kopp H
    Med Klin; 1967 Jun; 62(22):878-82. PubMed ID: 5594888
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the oral therapy of diabetes with oradian and chlorpropamide].
    Kaeding A; Werner P
    Dtsch Z Verdau Stoffwechselkr; 1967 Dec; 27(5):185-90. PubMed ID: 5595738
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of a new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).
    Seftel HC
    S Afr Med J; 1969 Aug; 43(32):979-80. PubMed ID: 4898091
    [No Abstract]   [Full Text] [Related]  

  • 17. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
    Duncan LJ; Clarke BF; Munro JF
    Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with ambulatory therapy of diabetics].
    Gasperoni G
    Fracastoro; 1968; 61(1):102-8. PubMed ID: 5739228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.